Integrated Brain Tissue–Serum Metabolomics Deciphers Brain–Blood Metabolic Coupling and the Mechanisms of Neurotoxic Metabolites in Cerebral Ischemia–Reperfusion Injury

Background: Cerebral ischemia–reperfusion injury (CIRI) remains a critical bottleneck underlying poor outcomes after ischemic stroke. However, the brain–blood metabolic coupling mechanism and the toxic role of endogenous metabolites have not been systematically elucidated. Most previous studies have treated differential metabolites as passive biomarkers of tissue injury, while their potential as active neurotoxic mediators that directly drive brain damage remains poorly understood. This study aimed to characterize brain–blood metabolic coupling and the neurotoxic mechanisms of differential metabolites in CIRI, and to identify candidate biomarkers with translational value. Methods: Thirty male specific pathogen-free Sprague–Dawley rats were randomly assigned to a sham-operated group or a middle cerebral artery occlusion/reperfusion (MCAO/R) model group, with 11 rats per group included in the final analysis. A paired brain tissue–serum design was employed, and UHPLC-MS/MS untargeted metabolomics was integrated with network toxicology, molecular docking, and molecular dynamics simulations to systematically dissect brain–blood metabolic coupling and metabolite toxicity in CIRI. Results: A total of 27 metabolites with differential abundance in both brain tissue and serum were identified. They showed three patterns: increased abundance in both compartments, decreased abundance in both compartments, and increased abundance in brain tissue with decreased abundance in serum. The two compartments shared 48 enriched pathways, and further prioritization identified 11 core metabolites and 21 core pathways. Network toxicology identified eight metabolites with in silico-predicted neurotoxic potential and BBB permeability, and linked their candidate targets to the PI3K-Akt, MAPK, and apoptosis pathways. Molecular docking and 100 ns molecular dynamics simulations supported the predicted binding poses and the stability of the selected metabolite–target complexes during the simulations. Conclusions: This study elucidates the brain–blood metabolic coupling mechanism of CIRI from the perspective of endogenous metabolic toxicity. Beyond serving as passive biomarkers, the eight prioritized metabolites are proposed as putative neurotoxic mediators that may contribute to CIRI by targeting the PI3K-Akt/MAPK signaling axes, based on computational prediction rather than experimental validation. The core metabolites identified in this study hold promise as candidate biomarkers for the early diagnosis and prognostic evaluation of ischemic stroke. The findings also provide a theoretical basis for precision intervention in CIRI and identify potential therapeutic targets.

Authors

Institutions

Publication Details

Journal
Metabolites
Published
2026-11-17
DOI
https://doi.org/10.3390/metabo16110901
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated Brain Tissue–Serum Metabolomics Deciphers Brain–Blood Metabolic Coupling and the Mechanisms of Neurotoxic Metabolites in Cerebral Ischemia–Reperfusion Injury

Wang‐Hua Liu, Nuan Cui, Jingxin Yao, Zhiguang Song et al.
Metabolites
Metabolomics and Mass Spectrometry Studies
article

Integrated Brain Tissue–Serum Metabolomics Deciphers Brain–Blood Metabolic Coupling and the Mechanisms of Neurotoxic Metabolites in Cerebral Ischemia–Reperfusion Injury

Wang‐Hua Liu, Nuan Cui, Jingxin Yao, Zhiguang Song, 谭诗敏, Jingyi Yang, Hua Li, Sile Cai
article en

Abstract

Background: Cerebral ischemia–reperfusion injury (CIRI) remains a critical bottleneck underlying poor outcomes after ischemic stroke. However, the brain–blood metabolic coupling mechanism and the toxic role of endogenous metabolites have not been systematically elucidated. Most previous studies have treated differential metabolites as passive biomarkers of tissue injury, while their potential as active neurotoxic mediators that directly drive brain damage remains poorly understood. This study aimed to characterize brain–blood metabolic coupling and the neurotoxic mechanisms of differential metabolites in CIRI, and to identify candidate biomarkers with translational value. Methods: Thirty male specific pathogen-free Sprague–Dawley rats were randomly assigned to a sham-operated group or a middle cerebral artery occlusion/reperfusion (MCAO/R) model group, with 11 rats per group included in the final analysis. A paired brain tissue–serum design was employed, and UHPLC-MS/MS untargeted metabolomics was integrated with network toxicology, molecular docking, and molecular dynamics simulations to systematically dissect brain–blood metabolic coupling and metabolite toxicity in CIRI. Results: A total of 27 metabolites with differential abundance in both brain tissue and serum were identified. They showed three patterns: increased abundance in both compartments, decreased abundance in both compartments, and increased abundance in brain tissue with decreased abundance in serum. The two compartments shared 48 enriched pathways, and further prioritization identified 11 core metabolites and 21 core pathways. Network toxicology identified eight metabolites with in silico-predicted neurotoxic potential and BBB permeability, and linked their candidate targets to the PI3K-Akt, MAPK, and apoptosis pathways. Molecular docking and 100 ns molecular dynamics simulations supported the predicted binding poses and the stability of the selected metabolite–target complexes during the simulations. Conclusions: This study elucidates the brain–blood metabolic coupling mechanism of CIRI from the perspective of endogenous metabolic toxicity. Beyond serving as passive biomarkers, the eight prioritized metabolites are proposed as putative neurotoxic mediators that may contribute to CIRI by targeting the PI3K-Akt/MAPK signaling axes, based on computational prediction rather than experimental validation. The core metabolites identified in this study hold promise as candidate biomarkers for the early diagnosis and prognostic evaluation of ischemic stroke. The findings also provide a theoretical basis for precision intervention in CIRI and identify potential therapeutic targets.

MetabolitesVol. 16(11)
Hunan University of Traditional Chinese Medicine (CN), Department of Science and Technology of Hunan Province (CN)
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon